MedPath

A study to evaluate the efficacy of third regimen with vonoprazan for eradication of Helicobacter pylori resistant against first and second regimen.

Not Applicable
Conditions
Helicobacter pylori infection
Registration Number
JPRN-UMIN000017061
Lead Sponsor
Shonan Kamakura General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
33
Inclusion Criteria

Not provided

Exclusion Criteria

A patient who took antibacterial drug or antacid drug within one month. A patient who has allergic hypersensitivity against the drugs used in this study. A patient who are judged to be inappropriate for this study by doctors conducting the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Eradication rate of Helicobacter pylori
Secondary Outcome Measures
NameTimeMethod
Rate of adverse events
© Copyright 2025. All Rights Reserved by MedPath